Sep 19, 2011
Judge Defines Scope Of Avandia Litigation
In the massive litigation over alleged side effects from the diabetes drug Avandia, a Pennsylvania federal judge has issued a pair of opinions that reject efforts by the drug’s maker, GlaxoSmithKline, to significantly limit the scope of the case.